English, , 849kb
The 2006 edition OECD Biotechnology Statistics includes data for 23 OECD countries and two observer countries, plus China (Shanghai), and takes a major step forward in improving the comparability of biotechnology indicators among countries.
English, , 436kb
This report documents the growing importance of intellectual assets for firms and the economy more generally and draws a number of implications for policy makers.
This paper provides an overview of innovative activities across a wide range of OECD member and non-member countries, based on internationally comparable patent indicators.
This joint OECD-Spanish government workshop on "Researcher Careers for the 21st Century" aimed to address key issues on researcher careers. A summary of the workshop is available here.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
Most OECD Member countries have a regulatory system for the products of modern biotechnology intended for release to the environment and for food/ feed use. This page includes links to portals of each member country which include relevant information.
This paper outlines factors that may affect the ability of researchers to access patented inventions for legitimate research purposes. It reviews evidence of access limitations and explores options for the formulation of research exemptions that balance research use and patent holders' rights.
This study shows how knowledge-intensive services activities (KISAs) contribute to the acquisition and growth capabilities of firms and public sector organisations.
Despite the attention that offshore outsourcing currently demands in the public media, there is little empirical evidence on its economic impact. This paper surveys the empirical literature on offshore outsourcing and its productivity effects.
These guidelines offer principles and best practices for the licensing of genetic inventions used for the purpose of human health care.